oxybutynin has been researched along with Asthma in 10 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
Excerpt | Relevance | Reference |
---|---|---|
"Tulobuterol patch (Tulo) is often used for treatment of elder patient with asthma in Japan." | 9.16 | [Clinical effects of budesonide/formoterol combination drug in elder patients with asthma compared with budesonide plus tulobuterol patch combination treatment]. ( Haruta, Y; Kondoh, K; Mukaida, K; Onari, Y, 2012) |
"Aggravation of asthmatic response (asthmatic attack, 2 cases) and adverse events (tremor, 1 case) due to a switch from a brand-name tulobuterol tape to a generic tape were recently reported." | 7.78 | [Questionnaire survey on the change of asthmatic response, adverse events and product usability due to drug switching between name-brand and generic tulobuterol tapes]. ( Hori, S; Izumi, T; Miki, A; Satoh, H; Sawada, Y, 2012) |
"Tulobuterol patch (Tulo) is often used for treatment of elder patient with asthma in Japan." | 5.16 | [Clinical effects of budesonide/formoterol combination drug in elder patients with asthma compared with budesonide plus tulobuterol patch combination treatment]. ( Haruta, Y; Kondoh, K; Mukaida, K; Onari, Y, 2012) |
"Aggravation of asthmatic response (asthmatic attack, 2 cases) and adverse events (tremor, 1 case) due to a switch from a brand-name tulobuterol tape to a generic tape were recently reported." | 3.78 | [Questionnaire survey on the change of asthmatic response, adverse events and product usability due to drug switching between name-brand and generic tulobuterol tapes]. ( Hori, S; Izumi, T; Miki, A; Satoh, H; Sawada, Y, 2012) |
"Tulobuterol patches are long-acting bronchodilators for percutaneous absorption including the β(2)-adrenoreceptor agonist tulobuterol, as a main ingredient, used for long-term management of pediatric asthma." | 3.76 | Comparative study of skin permeation profiles between brand and generic tulobuterol patches. ( Abe, T; Arisaka, O; Fukuda, H; Yoshihara, S, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 9 (90.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Axelrod, S | 1 |
Bielory, L | 1 |
Hong, JG | 1 |
Li, Z | 1 |
Inoue, H | 1 |
Niimi, A | 1 |
Matsumoto, H | 1 |
Ito, I | 1 |
Oguma, T | 1 |
Otsuka, K | 1 |
Takeda, T | 1 |
Nakaji, H | 1 |
Tajiri, T | 1 |
Iwata, T | 1 |
Nagasaki, T | 1 |
Mishima, M | 1 |
Zhou, F | 1 |
Wu, HJ | 1 |
Zhai, JP | 1 |
Zhang, GY | 1 |
Shao, Y | 1 |
Tian, X | 1 |
Xia, RY | 1 |
Jia, LY | 1 |
Li, WY | 1 |
Liang, N | 1 |
Yan, XY | 1 |
Wu, RH | 1 |
Zhang, K | 1 |
Li, XL | 1 |
Wang, CC | 1 |
Liu, JP | 1 |
Yoshihara, S | 1 |
Fukuda, H | 1 |
Abe, T | 1 |
Arisaka, O | 1 |
Hu, Y | 1 |
Wu, YY | 1 |
Xia, XJ | 1 |
Wu, Z | 1 |
Liang, WQ | 1 |
Gao, JQ | 1 |
Tamura, G | 1 |
Ichinose, M | 1 |
Fukuchi, Y | 1 |
Miyamoto, T | 1 |
Izumi, T | 1 |
Hori, S | 1 |
Satoh, H | 1 |
Miki, A | 1 |
Sawada, Y | 1 |
Tanaka, H | 1 |
Hozawa, S | 1 |
Kitada, J | 1 |
Fujii, M | 1 |
Onari, Y | 1 |
Haruta, Y | 1 |
Mukaida, K | 1 |
Kondoh, K | 1 |
3 reviews available for oxybutynin and Asthma
Article | Year |
---|---|
[Clinical application of transdermal beta-2 agonists for the wheezing diseases in childhood].
Topics: Adrenergic beta-2 Receptor Agonists; Asthma; Bronchitis; Bronchodilator Agents; Child; Child, Presch | 2013 |
Transdermal tulobuterol patch, a long-actingβ(2)-agonist.
Topics: Adrenergic beta-Agonists; Asthma; Bronchodilator Agents; Drug Approval; Evidence-Based Medicine; Hum | 2012 |
Impulse oscillometry; therapeutic impacts of transdermal long-acting Beta-2 agonist patch in elderly asthma with inhaled corticosteroid alone.
Topics: Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Aged; Aged, 80 and over; Anti-Asthmati | 2012 |
2 trials available for oxybutynin and Asthma
Article | Year |
---|---|
A 12-week, randomized, parallel-group, proof-of-concept study of tulobuterol patch and salmeterol inhaler as add-on therapy in adult-onset mild-to-moderate asthma.
Topics: Adult; Aged; Asthma; Bronchodilator Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Hu | 2017 |
[Clinical effects of budesonide/formoterol combination drug in elder patients with asthma compared with budesonide plus tulobuterol patch combination treatment].
Topics: Aged; Aged, 80 and over; Asthma; Biomarkers; Breath Tests; Bronchodilator Agents; Budesonide; Drug T | 2012 |
5 other studies available for oxybutynin and Asthma
Article | Year |
---|---|
Beta2-agonists and paresthesias in multiple sclerosis.
Topics: Adrenergic beta-Agonists; Albuterol; Amantadine; Analgesics, Non-Narcotic; Androstadienes; Aromatase | 2007 |
Who are the users of a traditional Chinese sanfu acupoint herbal patching therapy in China?: A cross-sectional survey.
Topics: Acupuncture Points; Adolescent; Adult; Age Factors; Aged; Ambulatory Care; Analysis of Variance; Art | 2016 |
Comparative study of skin permeation profiles between brand and generic tulobuterol patches.
Topics: Animals; Asthma; Bronchodilator Agents; Disease Models, Animal; Drugs, Generic; Female; Patents as T | 2010 |
Development of drug-in-adhesive transdermal patch for α-asarone and in vivo pharmacokinetics and efficacy evaluation.
Topics: Acrylates; Adhesives; Allylbenzene Derivatives; Animals; Anisoles; Asthma; Biological Availability; | 2011 |
[Questionnaire survey on the change of asthmatic response, adverse events and product usability due to drug switching between name-brand and generic tulobuterol tapes].
Topics: Aged; Asthma; Child, Preschool; Drug Substitution; Drug Utilization; Drugs, Generic; Female; Humans; | 2012 |